NO832151L - Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyridin-derivater - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyridin-derivaterInfo
- Publication number
- NO832151L NO832151L NO832151A NO832151A NO832151L NO 832151 L NO832151 L NO 832151L NO 832151 A NO832151 A NO 832151A NO 832151 A NO832151 A NO 832151A NO 832151 L NO832151 L NO 832151L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- carbon atoms
- formula
- pyrazolo
- methyl
- Prior art date
Links
Classifications
- 
        - C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
 
- 
        - C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
 
- 
        - C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
 
- 
        - C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/13—Monohydroxylic alcohols containing saturated rings
- C07C31/133—Monohydroxylic alcohols containing saturated rings monocyclic
- C07C31/1333—Monohydroxylic alcohols containing saturated rings monocyclic with a three-membered ring
 
- 
        - C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/34—Halogenated alcohols
- C07C31/38—Halogenated alcohols containing only fluorine as halogen
 
- 
        - C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
 
- 
        - C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/19—Acids containing three or more carbon atoms
- C07C53/21—Acids containing three or more carbon atoms containing fluorine
 
- 
        - C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
 
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB8217258 | 1982-06-15 | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| NO832151L true NO832151L (no) | 1983-12-16 | 
Family
ID=10531037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| NO832151A NO832151L (no) | 1982-06-15 | 1983-06-14 | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyridin-derivater | 
Country Status (12)
| Country | Link | 
|---|---|
| US (1) | US4552883A (en:Method) | 
| EP (1) | EP0096995A3 (en:Method) | 
| JP (1) | JPS5951283A (en:Method) | 
| AU (1) | AU1561083A (en:Method) | 
| DK (1) | DK276383D0 (en:Method) | 
| ES (1) | ES8504189A1 (en:Method) | 
| FI (1) | FI832148L (en:Method) | 
| GR (1) | GR79197B (en:Method) | 
| NO (1) | NO832151L (en:Method) | 
| NZ (1) | NZ204569A (en:Method) | 
| PT (1) | PT76862B (en:Method) | 
| ZA (1) | ZA834052B (en:Method) | 
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| GB8425104D0 (en) * | 1984-10-04 | 1984-11-07 | Ici America Inc | Amide derivatives | 
| GB8610981D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides | 
| ATE355841T1 (de) * | 1997-12-13 | 2007-03-15 | Bristol Myers Squibb Co | Verwendung von pyrazolo ( 3,4-b) pyridin als cyclin-abhängige kinase hemmer | 
| US20030220646A1 (en) * | 2002-05-23 | 2003-11-27 | Thelen Sarah L. | Method and apparatus for reducing femoral fractures | 
| US7425556B2 (en) * | 2005-12-20 | 2008-09-16 | Astrazeneca Ab | Compounds and uses thereof | 
| US7465795B2 (en) * | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof | 
| JP2007198640A (ja) * | 2006-01-25 | 2007-08-09 | Tigers Polymer Corp | 断熱ダクト用ジョイント | 
| AR067028A1 (es) * | 2007-06-19 | 2009-09-30 | Astrazeneca Ab | Compuestos y usos de los mismos 849 | 
| AU2011235069B2 (en) | 2010-04-02 | 2016-03-17 | Senomyx, Inc. | Sweet flavor modifier | 
| MY179876A (en) | 2011-08-12 | 2020-11-18 | Firmenich Incorporated | Sweet flavor modifier | 
| AU2015343463A1 (en) | 2014-11-07 | 2017-06-15 | Senomyx, Inc. | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers | 
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US3849411A (en) * | 1969-06-16 | 1974-11-19 | Squibb & Sons Inc | Hydrazones of pyrazolopyridine carboxylic acids and esters | 
| BE787249A (fr) * | 1971-08-05 | 1973-02-05 | Squibb & Sons Inc | Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation | 
| US4364948A (en) * | 1981-09-28 | 1982-12-21 | Ici Americas Inc. | Pyrazolo[3,4-b]pyridine compounds | 
- 
        1983
        - 1983-05-19 US US06/496,259 patent/US4552883A/en not_active Expired - Fee Related
- 1983-05-27 EP EP83303095A patent/EP0096995A3/en not_active Withdrawn
- 1983-06-03 ZA ZA834052A patent/ZA834052B/xx unknown
- 1983-06-03 GR GR71560A patent/GR79197B/el unknown
- 1983-06-08 AU AU15610/83A patent/AU1561083A/en not_active Abandoned
- 1983-06-14 NO NO832151A patent/NO832151L/no unknown
- 1983-06-14 JP JP58105100A patent/JPS5951283A/ja active Pending
- 1983-06-14 PT PT76862A patent/PT76862B/pt unknown
- 1983-06-14 FI FI832148A patent/FI832148L/fi not_active Application Discontinuation
- 1983-06-14 NZ NZ204569A patent/NZ204569A/en unknown
- 1983-06-15 DK DK2763/83A patent/DK276383D0/da not_active Application Discontinuation
- 1983-06-15 ES ES523282A patent/ES8504189A1/es not_active Expired
 
Also Published As
| Publication number | Publication date | 
|---|---|
| ZA834052B (en) | 1984-04-25 | 
| JPS5951283A (ja) | 1984-03-24 | 
| GR79197B (en:Method) | 1984-10-22 | 
| EP0096995A2 (en) | 1983-12-28 | 
| PT76862A (en) | 1983-07-01 | 
| US4552883A (en) | 1985-11-12 | 
| DK276383D0 (da) | 1983-06-15 | 
| PT76862B (en) | 1986-01-10 | 
| FI832148A7 (fi) | 1983-12-16 | 
| FI832148A0 (fi) | 1983-06-14 | 
| EP0096995A3 (en) | 1984-12-05 | 
| NZ204569A (en) | 1985-07-12 | 
| ES523282A0 (es) | 1985-02-16 | 
| FI832148L (fi) | 1983-12-16 | 
| ES8504189A1 (es) | 1985-02-16 | 
| AU1561083A (en) | 1983-12-22 | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| US4563525A (en) | Process for preparing pyrazolopyridine compounds | |
| DE69609371T2 (de) | Pyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| US5607936A (en) | Substituted aryl piperazines as neurokinin antagonists | |
| US5508300A (en) | Dihydro pyrazolopyrroles, compositions and use | |
| EP0042100A1 (de) | Pyrazolopyridazin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung, sowie diese enthaltende Arzneimittel | |
| NO832151L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyridin-derivater | |
| TW201619162A (zh) | 作為pde2抑制劑之經取代的5-甲基-[1,2,4]三唑并[1,5-a]嘧啶-2-胺化合物 | |
| NO744183L (en:Method) | ||
| DE60001138T2 (de) | Polycyclische Azaindolderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
| EP0094175B1 (en) | Pyrazolopyridine compounds | |
| RU2090565C1 (ru) | Рацемические или оптически активные пергидро-1h-пиридо(1,2-а) пиразины или их фармацевтически приемлемые соли и способ их получения | |
| EP2109611B1 (en) | 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase | |
| Yadav et al. | Synthesis of β-carboline-fused 1, 4-oxazepines and their assessment as antiplasmodial agents | |
| JPH0322390B2 (en:Method) | ||
| Raiman et al. | A convenient approach to the synthesis of 2-(2-aminoethyl) pyrroles and their heterocyclization into hydrogenated pyrrolopyridines and related pyrroloindolizines | |
| US4705793A (en) | Pyrazolo[3,4-b]pyrrolo[3,4-e]pyridine-5(1H)-one and 1-H-pyrazolo[3,4-b][1,6]naphthyridine-5(6H)-one derivations, useful as anti-anxiety agents | |
| EP0187711B1 (en) | Octahydroindolizine compounds useful as analgesics | |
| US3833594A (en) | Amino derivatives of pyrazolopyridine carboxylic acids and esters | |
| NO844376L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridin-cykloalkanon-derivater | |
| DD252376A5 (de) | Verfahren zur herstellung von hexohydro-(1)-benzo-(pyrane und thiopyrano)-4,3-c)pyridinen | |
| Oakes et al. | Broadened scope of translocative rearrangements. Substituted 1, 2, 3-triazolo [1, 5-a]-1, 3, 5-triazines | |
| SU906379A3 (ru) | Способ получени производных пиридо/1,2-а/пиримидинов или их солей,или их оптически активных изомеров | |
| DE60212357T2 (de) | Pyrrolderivate zur behandlung von durch cytokine vermittelte krankheiten | |
| JP2023539526A (ja) | インターフェロン遺伝子刺激因子stingのアゴニスト | |
| HU188071B (en) | Process for producing pyrrolo-benzodiazepine derivatives |